Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890

Disease

Nerve Degeneration 5 | 73
Neuropathy 5 | 210
Glaucoma 4 | 135
Neurodegenerative disease 4 | 383
Alzheimer's disease 3 | 644
Asthma 3 | 349
Autistic Disorder 3 | 320
Cancer 3 | 2,346
Cerebrovascular disease 3 | 231
Inflammation 3 | 109
Multiple Sclerosis 3 | 498
Obesity 3 | 616
Schizophrenia 3 | 503
Status Epilepticus 3 | 85
Tonic-clonic epilepsy 3 | 47
Toxic encephalopathy 3 | 131
diabetes mellitus 3 | 1,663
Allergic hypersensitivity disease 2 | 123
Amyotrophic Lateral Sclerosis 2 | 432
Bipolar Disorder 2 | 266
Cocaine-Related Disorders 2 | 88
Dementia 2 | 129
Dermatitis 2 | 141
Diabetic Neuropathies 2 | 13
Down syndrome 2 | 548
Endometriosis 2 | 535
Heroin dependence 2 | 30
Huntington's disease 2 | 72
Hyperalgesia 2 | 71
Intellectual disability 2 | 573
Kidney Failure, Chronic 2 | 45
Parkinson Disease 2 | 105
Parkinson's disease 2 | 364
Seizures 2 | 95
Sensorineural hearing loss 2 | 107
cystic fibrosis 2 | 1,670
glioblastoma 2 | 5,572
malignant mesothelioma 2 | 3,163
nervous system disorder 2 | 53
ovarian cancer 2 | 8,491
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
psoriasis 2 | 6,685
Acute Lung Injury 1 | 18
Amnesia 1 | 17
Amnestic disorder 1 | 37
Anhidrosis 1 | 12
Aortic aneurysm 1 | 34
Berylliosis 1 | 28
Bronchial Hyperreactivity 1 | 13
Bulimia nervosa 1 | 15
Calcinosis 1 | 63
Carcinosarcoma 1 | 6
Cerebral Hemorrhage 1 | 27
Chronic Kidney Insufficiency 1 | 5
Chronic Obstructive Airway Disease 1 | 47
Chronic fatigue syndrome 1 | 29
Complex regional pain syndrome 1 | 12
Cystitis 1 | 16
Diabetic Nephropathy 1 | 37
Diabetic Retinopathy 1 | 53
Diaphragmatic Hernia 1 | 40
Duodenal ulcer 1 | 20
Gliosis 1 | 16
Glomerulonephritis 1 | 36
Hereditary Sensory and Autonomic Neuropathies 1 | 4
Hereditary sensory neuropathy 1 | 6
Human immunodeficiency virus infectious disease 1 | 129
Hyperactive behavior 1 | 31
Hyperglycemia 1 | 120
Infarction, Middle Cerebral Artery 1 | 25
Lewy Body Disease 1 | 19
Loeys-Dietz syndrome 1 | 23
Lung Injury 1 | 20
Migraine Disorders 1 | 26
Myocardial Infarction 1 | 126
Neoplastic Cell Transformation 1 | 81
Nephrotic Syndrome 1 | 48
Neurodegenerative Disorders 1 | 37
Obesity, Morbid 1 | 6
Oral Submucous Fibrosis 1 | 18
Pain disorder 1 | 13
Pancreatitis 1 | 97
Papilloma 1 | 27
Parkinsonian Disorders 1 | 23
Peyronie's disease 1 | 8
Phaeochromocytoma 1 | 20
Psychotic Disorders 1 | 20
Pulmonary Fibrosis 1 | 66
Pulmonary emphysema 1 | 34
Retinal detachment 1 | 33
Schistosomiasis 1 | 38
Sepsis 1 | 21
Skin Neoplasms 1 | 49
Substance Withdrawal Syndrome 1 | 55
Substance abuse 1 | 55
Tetanus 1 | 66
Uremia 1 | 19
Ureteral disease 1 | 23
Ureteral obstruction 1 | 6

Tissue

Blood and immune system 6 | 17,994
Cardiovascular System 6 | 17,957
Digestive Tract 6 | 18,472
Endocrine System 6 | 18,511
Female tissues 6 | 18,646
Male tissues 6 | 17,968
Nervous System 6 | 18,560
Respiratory system 6 | 17,483
Liver and Pancreas 5 | 18,135
Skin and soft tissues 5 | 18,114
Urinary Tract 5 | 18,443

Target Family

Non-IDG 6 | 11,969

Grant Application

1R13NS041931-01 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Ciliary neurotrophic factor CNTF Tbio Non-IDG -2.94980 991.3 390
Neurotrophin-3 NTF3 Tbio Non-IDG -2.94965 906.5 400
Brain-derived neurotrophic factor BDNF Tbio Non-IDG -3.96811 9826.7 594
Neurotrophin-4 NTF4 Tbio Non-IDG -2.56720 351.0 363
Beta-nerve growth factor NGF Tchem Non-IDG -4.00388 10626.8 510
Transforming growth factor beta-1 TGFB1 Tchem Non-IDG -3.82684 20956.6 961